“Health Technology Assessment for Vaccines Against Rate, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination’s Full Social and Economic Benefits”
Andrew Stawasz
Frontiers in Public Health
2020
“Why Has Uptake of Pneumococcal Vaccines for Children Been So Slow? The Perils of Undervaluation”
Andrew Stawasz
The Pediatric Infectious Disease Journal
2020
“Indirect Costs of Adult Pneumococcal Disease and the Productivity-Based Rate of Return to the 13-Valent Pneumococcal Conjugate Vaccine for Adults in Turkey”
Andrew Stawasz
Human Vaccines and Immunotherapueutics
2020